The role of TSC2 in breast cancer: a literature review

TSC2 is a tumor suppressor gene as well as a disease-causing gene for autosomal dominant disorder tuberous sclerosis complex (TSC). Research has found that some tumor tissues have lower TSC2 expression levels than normal tissues. Furthermore, low expression of TSC2 is associated with poor prognosis...

Full description

Bibliographic Details
Main Authors: Qiao-Yan Zhu, Zhe-Min He, Wen-Ming Cao, Bei Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1188371/full
_version_ 1797828938730307584
author Qiao-Yan Zhu
Qiao-Yan Zhu
Zhe-Min He
Zhe-Min He
Wen-Ming Cao
Bei Li
author_facet Qiao-Yan Zhu
Qiao-Yan Zhu
Zhe-Min He
Zhe-Min He
Wen-Ming Cao
Bei Li
author_sort Qiao-Yan Zhu
collection DOAJ
description TSC2 is a tumor suppressor gene as well as a disease-causing gene for autosomal dominant disorder tuberous sclerosis complex (TSC). Research has found that some tumor tissues have lower TSC2 expression levels than normal tissues. Furthermore, low expression of TSC2 is associated with poor prognosis in breast cancer. TSC2 acts as a convergence point of a complex network of signaling pathways and receives signals from the PI3K, AMPK, MAPK, and WNT pathways. It also regulates cellular metabolism and autophagy through inhibition of a mechanistic target of rapamycin complex, which are processes relevant to the progression, treatment, and prognosis of breast cancer. In-depth study of TSC2 functions provides significant guidance for clinical applications in breast cancer, including improving the treatment efficacy, overcoming drug resistance, and predicting prognosis. In this review, protein structure and biological functions of TSC2 were described and recent advances in TSC2 research in different molecular subtypes of breast cancer were summarized.
first_indexed 2024-04-09T13:12:25Z
format Article
id doaj.art-79dea11679ca47b3b3b64af279fc994c
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T13:12:25Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-79dea11679ca47b3b3b64af279fc994c2023-05-12T06:05:14ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-05-011310.3389/fonc.2023.11883711188371The role of TSC2 in breast cancer: a literature reviewQiao-Yan Zhu0Qiao-Yan Zhu1Zhe-Min He2Zhe-Min He3Wen-Ming Cao4Bei Li5The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, ChinaThe Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, ChinaDepartment of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, ChinaDepartment of Geriatric, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaTSC2 is a tumor suppressor gene as well as a disease-causing gene for autosomal dominant disorder tuberous sclerosis complex (TSC). Research has found that some tumor tissues have lower TSC2 expression levels than normal tissues. Furthermore, low expression of TSC2 is associated with poor prognosis in breast cancer. TSC2 acts as a convergence point of a complex network of signaling pathways and receives signals from the PI3K, AMPK, MAPK, and WNT pathways. It also regulates cellular metabolism and autophagy through inhibition of a mechanistic target of rapamycin complex, which are processes relevant to the progression, treatment, and prognosis of breast cancer. In-depth study of TSC2 functions provides significant guidance for clinical applications in breast cancer, including improving the treatment efficacy, overcoming drug resistance, and predicting prognosis. In this review, protein structure and biological functions of TSC2 were described and recent advances in TSC2 research in different molecular subtypes of breast cancer were summarized.https://www.frontiersin.org/articles/10.3389/fonc.2023.1188371/fullTSC2breast cancersignaling pathwaysmTORPI3K
spellingShingle Qiao-Yan Zhu
Qiao-Yan Zhu
Zhe-Min He
Zhe-Min He
Wen-Ming Cao
Bei Li
The role of TSC2 in breast cancer: a literature review
Frontiers in Oncology
TSC2
breast cancer
signaling pathways
mTOR
PI3K
title The role of TSC2 in breast cancer: a literature review
title_full The role of TSC2 in breast cancer: a literature review
title_fullStr The role of TSC2 in breast cancer: a literature review
title_full_unstemmed The role of TSC2 in breast cancer: a literature review
title_short The role of TSC2 in breast cancer: a literature review
title_sort role of tsc2 in breast cancer a literature review
topic TSC2
breast cancer
signaling pathways
mTOR
PI3K
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1188371/full
work_keys_str_mv AT qiaoyanzhu theroleoftsc2inbreastcanceraliteraturereview
AT qiaoyanzhu theroleoftsc2inbreastcanceraliteraturereview
AT zheminhe theroleoftsc2inbreastcanceraliteraturereview
AT zheminhe theroleoftsc2inbreastcanceraliteraturereview
AT wenmingcao theroleoftsc2inbreastcanceraliteraturereview
AT beili theroleoftsc2inbreastcanceraliteraturereview
AT qiaoyanzhu roleoftsc2inbreastcanceraliteraturereview
AT qiaoyanzhu roleoftsc2inbreastcanceraliteraturereview
AT zheminhe roleoftsc2inbreastcanceraliteraturereview
AT zheminhe roleoftsc2inbreastcanceraliteraturereview
AT wenmingcao roleoftsc2inbreastcanceraliteraturereview
AT beili roleoftsc2inbreastcanceraliteraturereview